Mucus Relief Extended Release
NDC 0536-1163, Guaifenesin, tablet, extended release, from Rugby Laboratories, Inc..
- Product NDC
- 0536-1163
- Status
- Listed
- Labeler
- Rugby Laboratories, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA207342
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0536-1163 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN600 mg/1
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0536-1163-61 | 00536116361 | 100 BLISTER PACK in 1 CARTON (0536-1163-61) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
NADAC price for package 00536116361
GET /v1/drugs/nadac/00536116361
Use it
Look up 0536-1163 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0536-1163 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0536-1163. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.